Medicare Enrolled
Dr. Nina Maouelainin, D.O
Critical Care Medicine · Lansdale, PA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Speaking/Promotional
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Maouelainin from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Maouelainin?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Maouelainin
Dr. Nina Maouelainin is a critical care medicine specialist in Lansdale, PA, with 17 years of NPI registration. Based on federal Medicare data, Dr. Maouelainin performed 3,191 Medicare services across 1,872 unique beneficiaries.
Between the years covered by Open Payments, Dr. Maouelainin received a total of $44,221 from 51 pharmaceutical and/or device companies across 733 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in critical care medicine. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Maouelainin is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 17 years in practice
▲ Top 3% volume in PA
$44,221 industry payments
Medicare Practice Summary
Medicare Utilization ↗3,191
Medicare services
Top 3% in PA for critical care medicine
1,872
Unique beneficiaries
$66
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~188 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
733 | $98 | $345 |
| Remote patient monitoring management, 20 min/month Management based on results from remote vital sign monitoring for the first 20 minutes per calendar month. |
555 | $39 | $266 |
| Remote patient monitoring device, 30 days Initial setup of devices for remote monitoring of body functions with daily data transmission or alerts. This service covers the first 30 days of the monitoring period. |
542 | $40 | $213 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
297 | $69 | $236 |
| Expiratory airflow and volume test A test that measures the amount of air you can exhale and the speed at which you can breathe it out. It evaluates lung function by assessing expiratory airflow and volume. |
153 | $22 | $118 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
102 | $135 | $528 |
| Pulmonary gas exchange test A test to examine how well the lungs exchange gases. |
93 | $45 | $179 |
| Remote vital sign monitoring management, each additional 20 minutes This code covers the time spent by a provider managing patient data from remote vital sign monitoring devices. It applies to each additional 20-minute increment beyond the initial monthly service period. |
86 | $32 | $289 |
| Spirometry test before and after medication A test that measures the amount of air you can exhale and the speed of your breathing before and after taking a medication. |
77 | $29 | $199 |
| Bronchial irrigation and suction for cell collection This procedure uses an endoscope to flush and suction the lung airways in order to collect cells for testing. |
67 | $17 | $523 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
52 | $92 | $358 |
| Lung biopsy via endoscope, 1 lobe A procedure to remove a small sample of lung tissue from one lobe using an endoscope for examination. |
51 | $72 | $502 |
| Lung volume test using sensors A test that measures the amount of air in the lungs using sensors. |
46 | $46 | $180 |
| Computer-assisted navigation of lung airways This procedure uses computer technology to guide an endoscope through the airways of the lungs for precise navigation. |
42 | $79 | $2,484 |
| Bronchoscopy with ultrasound and lymph node sampling A procedure using an endoscope and ultrasound to examine the lung airways and collect samples from 1 to 2 lymph nodes. |
39 | $153 | $1,175 |
| Respiratory virus nucleic acid test, 3-5 targets A laboratory test that uses nucleic acid detection to identify multiple types or subtypes of respiratory viruses. The test analyzes 3 to 5 specific viral targets. |
38 | $140 | $750 |
| Telephone medical discussion, 21-30 minutes A telephone conversation with a physician lasting between 21 and 30 minutes. This code covers the time spent discussing medical matters over the phone. |
34 | $103 | $244 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
33 | $148 | $469 |
| Telephone medical discussion, 11-20 minutes A phone conversation with a physician lasting between 11 and 20 minutes. |
32 | $68 | $172 |
| Endoscopic needle biopsy of windpipe, airway, or lung A procedure where a needle is inserted through an endoscope to collect tissue samples from the windpipe, airway, or lung. |
22 | $138 | $974 |
| Inhaled albuterol and ipratropium bromide via DME Administration of FDA-approved albuterol and ipratropium bromide medication through durable medical equipment. |
22 | $0 | $36 |
| Bronchial secretion aspiration via endoscope Removal of initial lung airway secretions using an endoscope. This procedure involves inserting a scope into the airways to clear fluid or mucus. |
21 | $54 | $619 |
| Lung volume test using gas dilution or washout A test that measures the amount of air in your lungs by using a gas dilution or washout method. |
21 | $37 | $144 |
| New patient office visit, complex (60-74 min) | 21 | $172 | $670 |
| Placement of radiation therapy markers in lung airways A procedure where small markers are placed into the airways of the lung using an endoscope to assist with radiation therapy targeting. |
12 | $114 | $1,168 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$44,221
Total received (2018-2024)
Avg $6,317/year across 7 years
Top 5% in PA for critical care medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
51
Companies
733
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$22,889 (51.8%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$12,889 (29.1%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$8,443 (19.1%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$17,813
2023
$3,694
2022
$1,017
2021
$3,140
2020
$4,705
2019
$11,381
2018
$2,472
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
INTUITIVE SURGICAL, INC.
$11,461
AstraZeneca Pharmaceuticals LP
$4,668
GlaxoSmithKline, LLC.
$452
Amgen Inc.
$217
Mylan Specialty L.P.
$183
GENZYME CORPORATION
$173
Noah Medical Corporation
$127
Mallinckrodt Hospital Products Inc.
$103
Insmed, Inc.
$102
SANOFI-AVENTIS U.S. LLC
$79
Pulmonx Corporation
$54
ANI Pharmaceuticals, Inc.
$53
Daiichi Sankyo Inc.
$52
Paratek Pharmaceuticals, Inc.
$37
Regeneron Healthcare Solutions, Inc.
$32
Electromed, Inc.
$19
Top 3 companies account for 93.1% of 2024 payments
All-time payments by company (2018-2024) ›
Mylan Specialty L.P.
$13,339
INTUITIVE SURGICAL, INC.
$11,461
AstraZeneca Pharmaceuticals LP
$6,805
GlaxoSmithKline, LLC.
$2,277
Body Vision Medical Inc.
$2,200
Philips Electronics North America Corporation
$753
Sunovion Pharmaceuticals Inc.
$732
Boehringer Ingelheim Pharmaceuticals, Inc.
$660
Ethicon Inc.
$659
Veran Medical Technologies, Inc.
$448
Noah Medical Corporation
$402
Amgen Inc.
$380
Pulmonx Corporation
$357
GENZYME CORPORATION
$310
Insmed, Inc.
$299
Advanced Respiratory, Inc
$280
Mallinckrodt LLC
$259
Actelion Pharmaceuticals US, Inc.
$248
Mallinckrodt Enterprises LLC
$238
Mallinckrodt Hospital Products Inc.
$228
Baxter Healthcare
$164
Regeneron Healthcare Solutions, Inc.
$157
Genentech USA, Inc.
$157
Grifols USA, LLC
$141
SANOFI-AVENTIS U.S. LLC
$100
Boston Scientific Corporation
$98
Teva Pharmaceuticals USA, Inc.
$97
Foundation Medicine, Inc.
$84
Novartis Pharmaceuticals Corporation
$80
Takeda Pharmaceuticals U.S.A., Inc.
$75
BioFire Diagnostics, LLC
$74
Axsome Therapeutics, Inc.
$63
ANI Pharmaceuticals, Inc.
$53
Daiichi Sankyo Inc.
$52
Shire North American Group Inc
$48
Optinose US, Inc.
$38
Merck Sharp & Dohme Corporation
$37
Paratek Pharmaceuticals, Inc.
$37
Circassia Pharmaceuticals Inc
$37
HARMONY BIOSCIENCES LLC
$36
Harmony Biosciences LLC
$35
Electromed, Inc.
$33
ARBOR PHARMACEUTICALS, INC.
$31
JAZZ PHARMACEUTICALS INC.
$30
Olympus America Inc.
$26
Jazz Pharmaceuticals Inc.
$24
Resmed Corp
$19
kaleo, Inc.
$17
Genentech, Inc.
$16
Vapotherm Inc
$13
Kaleo, Inc.
$12
Top 3 companies account for 71.5% of all-time payments
Associated products mentioned in payments ›
(8874) inCourage · ACQUIRE · ACTHAR · AIRCURVE · AIRSUPRA · ANORO · ANORO ELLIPTA · ARALAST · AREXVY · AUVI-Q · AirDuo Digihaler · Arikayce · BEVESPI AEROSPHERE · BREO · BREZTRI · BREZTRI AEROSPHERE · BROVANA · BioFire FilmArray · CHARTIS CATHETER · CINQAIR · DUAKLIR PRESSAIR · DUPIXENT · Da Vinci Surgical System · Dymista · Enhertu · Esbriet · Evekeo · FASENRA · FOUNDATIONONE · GALAXY · GLASSIA · Hillrom - Life 2000 Ventilation System · IMFINZI · KEYTRUDA · LATUDA · LONHALA MAGNAIR · Life 2000 Ventilation System · LungVision · MONARCH · Monarch Platform · NO PRODUCT DISCUSSED · NUCALA · NUZYRA · OFEV · OPSUMIT · OPSUMIT MACITENTAN · PURIFIED CORTROPHIN GEL · Perforomist · Precision Flow · ProAir Digihaler · Prolastin-C · Prolastin-C Liquid · Pulmonx Endobronchial Valve EBV · Respiratoriy Care Undiv · S&RC Und · SMARTVEST · SPIRIVA · SPIRIVA RESPIMAT · STIOLTO · STIOLTO RESPIMAT · SYMBICORT · Single Use Biliary Stent V · Spin · Sunosi · TEZSPIRE · TRELEGY ELLIPTA · TUDORZA PRESSAIR · The Monarch Airway Clearance System · The Vest System Model 105 Home Care · Trilogy 100 · UPTRAVI · UTIBRON NEOHALER · Utibron · Volara System · WAKIX · Wakix · Wellcentive Undiv · XOLAIR · XYREM · Xhance · Xofluza · Xolair · YUPELRI · Yupelri · ZEPHYR DELIVERY CATHETER · ZEPHYR ENDOBRONCHIAL VALVE · inCourage
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (52%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in critical care medicine and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 5% for critical care medicine in PA.
Geographic Context
Critical care medicines within 10 mi
131
Per 100K population
15.2
County median income
$111,521
Nearest hospital
JEFFERSON LANSDALE HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Maouelainin is a clinical cardiology specialist, with above-average Medicare volume (top 3% in PA), with speaking/promotional industry engagement in the top 5% of PA peers, with 17 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Maouelainin experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Maouelainin performed 733 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Maouelainin receive payments from pharmaceutical companies?
Yes. Dr. Maouelainin received a total of $44,221 from 51 companies across 733 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Maouelainin's costs compare to other critical care medicines in Lansdale?
Dr. Maouelainin's average Medicare payment per service is $66. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Maouelainin) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Critical Care Medicines in Lansdale
Browse critical care medicines in Lansdale ranked by procedure volume and transparency data.
Highest volume
Top Critical Care Medicines in PA
Critical care medicines ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Critical Care Medicines in PA
Which PA critical care medicines receive the most from drug and device companies.
By company
Mylan Specialty L.P. Payments to Doctors
See all physicians who received payments from Mylan Specialty L.P.
By company
INTUITIVE SURGICAL, INC. Payments to Doctors
See all physicians who received payments from INTUITIVE SURGICAL, INC.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology